Orchestra BioMed director buys 5,000 shares
Orchestra BioMed Holdings, Inc. director and officer David P. Hochman reported an open-market purchase of 5,000 shares of Common Stock on June 1, 2026 at a weighted average price of $3.83 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Orchestra BioMed Holdings, Inc. director and officer David P. Hochman reported an open-market purchase of 5,000 shares of Common Stock on June 1, 2026 at a weighted average price of $3.83 per share. After this transaction, he directly holds 1,064,029 shares of Common Stock.
Additional shares are held indirectly through various family trusts, including 439,482 shares held by the DPH 2008 Trust and smaller positions held by several 2008 and 2019 family trusts.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock, par value $0.0001 per share ("Common Stock") | 5,000 | $3.83 | $19K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.80 to $3.91. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Key Figures
Key Terms
open-market purchase financial
weighted average price financial
indirect ownership financial
family trust financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did OBIO report for David P. Hochman?
What indirect OBIO holdings are reported for David P. Hochman?
Was the OBIO insider transaction a buy or sell according to the Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.